BioAssays is a biotechnological platform focused on the research and development of innovative safe, reliable and fast diagnostic systems for viral infections.
In vitro diagnostic systems for flavivirus: Hepatitis C (HCV) & Zika (ZIKV) virus
In vitro diagnostic system for avian Metapneumovirus (aMPV)
Biotechnology: Hombiocat project
Prophylactic vaccines for African Swine Fever Virus (ASFV)
Screening and analysis of protein interactions
Coprecipitation, affinity chromatography, SPR (Biacore), yeast two-hybrid (Y2H), etc.
Genetics y proteomics
Gene subcloning, expression and purification of proteins, PCR, development of chimeras, mutagenesis, mini-libraries of mutants, cDNA or genomic DNA libraries, shRNA constructs, epigenetics, etc.
Cell culture and single cell assays
Microscopy: optical, confocal, real-time video recording, immunofluorescence, FRAP, FLIP, FRET & FLIM, transfection, gene silencing, toxicity analysis, flow cytometry, isolation and cell shorting, Mycoplasma detection, etc.
Cell signalling pathways, cell adhesion and migration, cytoskeleton remodelling, endocytosis and vesicle trafficking, post-translational modifications, viral infection assays, etc.
BioAssays submits a proposal for new ISCIII Covid-19 call19 March 2020
ISCIII (Institute of Health Carlos III), under Spanish Ministry of Science and Innovation, has launched an extraordinary funding call for proposals on...
BioAssays submits a proposal for new IMI2 Covid-19 call (Horizon 2020)4 March 2020
Committed to the fight against the emerging SARS-CoV-2 coronavirus, responsible for the ongoing pandemic of Covid-19, designated Public Health Emergen...
For any additional information or proposal about BioAssays available services, please, feel free to contact us:
Calle Faraday, 7.
PCM. Parque Científico de Madrid.
Phone: (+34) 652274385